Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders [Phase 4]

View source ↗

Summary

Phase 4 study evaluating drug-drug interactions between TPOXX (tecovirimat) and phosphate binders has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPOXX (tecovirimat monohydrate)

Snippet

Sponsor: SIGA Technologies | Conditions: Smallpox | Phase 4 | Status: COMPLETED | Results posted: 2024-10-09